Type 2 diabetes mellitus ICD11 code: 5A11
Neutral insulin injection
including quality-assured biosimilars
Parenteral > General injections > SC: 40 IU per mL in 10 mL vial (soluble) ; 100 IU per mL in 10 mL vial (soluble) ; 100 IU per mL in 3 mL cartridge (soluble) ; 100 IU per mL in 3 mL pre-filled pen (soluble)
EML status history
Adolescents and adults
The recommendation is for this specific medicine
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended that the current listings for human insulin on the core list of the EML and EMLc be extended to include cartridge and pre-filled pen delivery systems. The Committee considered that cartridges and pre-filled pens may offer advantages for patients over vials and syringes in terms of ease of use, greater accuracy of dosing and improved adherence. The Committee acknowledged that affordable access to insulin products remains a critical global health priority.